☆ 4.5 Article

Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

MYCOPATHOLOGIA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE) : a multicentre, double-blind, double-dummy, randomised phase 3 trial

George R. Thompson III et al.

Summary: This study compared the efficacy and safety of intravenous rezafungin with intravenous caspofungin in the treatment of candidaemia and invasive candidiasis. The results showed that rezafungin was non-inferior to caspofungin in terms of efficacy and safety.

LANCET (2023)

添加到收藏夹

Article Microbiology

Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris In Vitro

Larissa L. H. John et al.

Summary: Candida auris is an emerging, multidrug-resistant fungal pathogen that causes refractory colonization and life-threatening, invasive nosocomial infections. The high proportion of C. auris isolates that display antifungal resistance severely limits treatment options.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

添加到收藏夹

Article Microbiology

Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis

Martin Hoenigl et al.

Summary: Timely diagnosis remains an unmet need in non-neutropenic patients at risk for aspergillosis, including those with COVID-19-associated pulmonary aspergillosis (CAPA). Currently available mycological tests show limited sensitivity when testing blood specimens. Metagenomic next-generation sequencing (mNGS) to detect microbial cell-free DNA (mcfDNA) in plasma might overcome some of the limitations of conventional diagnostics.

JOURNAL OF CLINICAL MICROBIOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Fungal translocation measured by serum 1,3-β-D-glucan correlates with severity and outcome of liver cirrhosis-A pilot study

Matthias Egger et al.

Summary: Liver cirrhosis, a systemic disease causing 1 million deaths per year, is associated with fungal translocation and its effects on gut integrity, inflammation, and liver disease severity/outcome. This study found a correlation between fungal translocation and markers of gut inflammation, as well as a significant difference in mortality between patients with positive versus negative fungal translocation. Further research is needed to understand the complex interactions and potential therapeutic interventions.

LIVER INTERNATIONAL (2023)

添加到收藏夹

Article Mycology

Epidemiology and Outcomes of Non-albicans Candida Bloodstream Infections in Transplant Recipients and Cancer Patients

Caitlin Otto et al.

Summary: This retrospective survey conducted in New York City analyzed non-Candida albicans candidemia in cancer and transplant patients. The most common species detected were C. glabrata, followed by C. parapsilosis, C. tropicalis, C. krusei, C. lusitaniae, and C. guilliermondii. Micafungin was the most commonly used antifungal treatment and 18.5% of patients received antifungal prophylaxis. The 30-day crude mortality rate was 40%. This study provides valuable epidemiological data on non-albicans Candida species in this patient population.

MYCOPATHOLOGIA (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action

Martin Hoenigl et al.

Summary: Infections caused by non-albicans Candida spp. are increasing, but the development of antifungal drugs is still progressing. The article discusses in detail the antifungal agents currently in clinical development for Candida, their mechanisms of action, and pharmacokinetic and pharmacodynamic properties. Expert opinions are provided on the potential roles of these investigational agents.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

添加到收藏夹

Article Infectious Diseases

The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey

Jon Salmanton-García et al.

Lancet Microbe (2022)

添加到收藏夹

Review Microbiology

COVID-19-associated fungal infections

Martin Hoenigl et al.

Summary: Invasive fungal infections associated with COVID-19 are an important complication, primarily caused by Aspergillus, Mucorales, and Candida species. This review examines the incidence of these fungal infections in different income countries, evaluating their epidemiology, clinical risk factors, and pathogenesis for future research and clinical guidance. Hoenigl and colleagues provide an overview of the epidemiology, immunology, and clinical risk factors of COVID-19-associated fungal infections.

NATURE MICROBIOLOGY (2022)

添加到收藏夹

Article Immunology

Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU

Farnaz Daneshnia et al.

Summary: Patients with severe COVID-19 are at risk of acquiring COVID-19-associated candidemia (CAC), often caused by drug-resistant C. parapsilosis. This study reports the largest outbreak of CAC caused by fluconazole-resistant and echinocandin-tolerant C. parapsilosis. The findings underscore the importance of antifungal stewardship and infection control strategies.

EMERGING MICROBES & INFECTIONS (2022)

添加到收藏夹

Review Microbiology

Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections

David A. Angulo et al.

Summary: Molds pose a significant risk to immunocompromised patients, and current antifungal therapies have limitations. Ibrexafungerp, a new class of antifungal, shows promise with its oral availability, tissue penetration, and efficacy against invasive mold infections.

JOURNAL OF FUNGI (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

Martin Hoenigl et al.

Summary: The epidemiology of invasive fungal infections is changing due to increased usage of antifungal agents leading to resistance. Limited therapeutic options are further challenged by drug-drug interactions, toxicity, and administration constraints. Despite the lack of new antifungal drug classes in the past two decades, there are promising new classes in late-stage clinical development, offering hope for improved treatment options.

DRUGS (2021)

添加到收藏夹

Article Immunology

Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies

E. Moreno-Garcia et al.

Summary: Early de-escalation to fluconazole is a safe strategy in patients with candidemia caused by fluconazole-susceptible strains with controlled source of bloodstream infection and hemodynamic stability, without significant impact on mortality rates.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Microbiology

First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and/or Y132F+K143R in Turkey

Amir Arastehfar et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

添加到收藏夹

Review Infectious Diseases

Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis

P. Koehler et al.

CLINICAL MICROBIOLOGY AND INFECTION (2019)

添加到收藏夹

Article Dermatology

ECMM CandiReg-A ready to use platform for outbreaks and epidemiological studies

Philipp Koehler et al.

MYCOSES (2019)

添加到收藏夹

Article Critical Care Medicine

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project

Matteo Bassetti et al.

CRITICAL CARE (2019)

添加到收藏夹

Article Medicine, General & Internal

Invasive candidiasis

Peter C. Pappas et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

添加到收藏夹

Article Dermatology

FungiScope™ - Global Emerging Fungal Infection Registry

Danila Seidel et al.

MYCOSES (2017)

添加到收藏夹

Article Immunology

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Peter G. Pappas et al.

CLINICAL INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Critical Care Medicine

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data

Sebastien Bailly et al.

INTENSIVE CARE MEDICINE (2015)

添加到收藏夹

Article Infectious Diseases

Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006–2008)

L. Klingspor et al.

CLINICAL MICROBIOLOGY AND INFECTION (2014)

添加到收藏夹

Article Infectious Diseases

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain

M. Puig-Asensio et al.

CLINICAL MICROBIOLOGY AND INFECTION (2014)

添加到收藏夹

Review Infectious Diseases

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

O. A. Cornely et al.

CLINICAL MICROBIOLOGY AND INFECTION (2012)

添加到收藏夹

Article Infectious Diseases

Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study

AM Tortorano et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.